AdamIraSherwatMD

Assistant Professor, Medicine, Georgetown University School of Medicine

Are you Dr. Sherwat?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 32 invites waiting!
Read the latest clinical news, personalized to your specialty.

Dr. Adam Sherwat, MD is an infectious disease specialist in Washington, District of Columbia. He is currently licensed to practice medicine in Maryland. He is an Assistant Professor at Georgetown University School of Medicine.

MedStar Health/Georgetown University HospitalFellowship, Infectious Disease, 2003 - 2005
Christ HospitalResidency, Internal Medicine, 1996 - 1999
University of Cincinnati College of MedicineClass of 1996

PubMed

81 citations
Tecovirimat and the Treatment of Monkeypox - Past, Present, and Future Considerations.
Adam Sherwat, John T Brooks, Debra Birnkrant, Peter Kim
The New England Journal of Medicine. 2022-08-18
122 citations
FDA Approval of Remdesivir - A Step in the Right Direction.
Daniel B. Rubin, Kirk M Chan-Tack, John Farley, Adam Sherwat
The New England Journal of Medicine. 2020-12-02
22 citations
Assessing a drug for an eradicated human disease: US Food and Drug Administration review of tecovirimat for the treatment of smallpox.
Kirk M Chan-Tack, Patrick R. Harrington, Su-Young Choi, Laine Myers, Julian J. O'Rear
The Lancet. Infectious Diseases. 2019-06-01

Sept. 16, 2022: National Advocacy UpdateSeptember 16th, 2022
FDA Warns Monkeypox Could Mutate if Antiviral Drug Is OverusedSeptember 14th, 2022
What Physicians Need to Know About Tecovirimat (TPOXX) for Treatment of MonkeypoxSeptember 13th, 2022
Join now to see all